OneMedNet Partnered With Mediplexus for Data Access
The agreement allows Mediplexus to distribute U.S. healthcare data throughout Korea and the Asia Pacific region.
Updated on Oct. 7, 2026 in Healthcare
Live Poll
Do you believe international medical data sharing partnerships improve healthcare innovation in your country?
OneMedNet has signed a partnership agreement with Mediplexus, a subsidiary of C&R Research. The deal focuses on distributing U.S.-sourced real-world health data to support companies in Korea and the Asia Pacific region.
Why it matters
The partnership aims to assist Korean medical device and artificial intelligence firms as they navigate the regulatory requirements of entering the U.S. market. It reflects a global shift toward the formal adoption of real-world data in regulatory processes.
OneMedNet maintains an iRWD network encompassing 90 million patient journeys across 2,300 healthcare partner sites. The broader global real-world evidence solutions market was valued at USD 5.4 billion in 2025.
The players
OneMedNet
OneMedNet is a healthcare company based in Minneapolis that specializes in providing real-world data through its iRWD network.
Mediplexus
Mediplexus is a Korean-based subsidiary of C&R Research that provides regulatory and market-access support for medical data.
The details
Under this initial one-year engagement, Mediplexus will combine OneMedNet's U.S. data with its own Korean healthcare information to provide analysis and market-access support. This marks OneMedNet's 11th channel partner agreement, expanding its reach as it manages a network containing 270 million studies.
Timeline
The agreement between OneMedNet and Mediplexus was signed on October 7, 2026.
The global market for real-world evidence solutions was valued at USD 5.4 billion in 2025.
The global RWE market is projected to reach USD 10.8 billion by 2030.
Market Landscape
This deal aligns with the broader industry trend toward global regulatory convergence, highlighted by the 2025 adoption of the ICH M14 guideline. By securing this partnership, OneMedNet expands its competitive footprint against other data providers in the Asia Pacific region.
The partnership helps streamline the market entry process for medical device and AI companies, potentially accelerating the availability of new health technologies. Average consumers may see a faster introduction of innovative medical products in the U.S. and Korean markets.
The takeaway
The growth of real-world evidence markets underscores the increasing importance of data-driven insights in global healthcare regulations. Companies that effectively bridge regional data gaps are better positioned to facilitate international medical innovation.
Further reading
For more on industry developments, visit the Healthcare section.
More information
Find more details on the company's network and services on the OneMedNet corporate website.
Live Poll
Do you believe international medical data sharing partnerships improve healthcare innovation in your country?
